Jesper Eugen‐Olsen

12.2k total citations
192 papers, 7.8k citations indexed

About

Jesper Eugen‐Olsen is a scholar working on Epidemiology, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jesper Eugen‐Olsen has authored 192 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Epidemiology, 45 papers in Infectious Diseases and 45 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jesper Eugen‐Olsen's work include Protease and Inhibitor Mechanisms (25 papers), HIV Research and Treatment (24 papers) and Adipokines, Inflammation, and Metabolic Diseases (17 papers). Jesper Eugen‐Olsen is often cited by papers focused on Protease and Inhibitor Mechanisms (25 papers), HIV Research and Treatment (24 papers) and Adipokines, Inflammation, and Metabolic Diseases (17 papers). Jesper Eugen‐Olsen collaborates with scholars based in Denmark, United States and Guinea-Bissau. Jesper Eugen‐Olsen's co-authors include Betina Macho, Ove Andersen, Line Jee Hartmann Rasmussen, Janne Petersen, Klaus F. Kofoed, Thomas Benfield, Morten Rühwald, Steen B. Haugaard, Pernille Ravn and Gitte Kronborg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Jesper Eugen‐Olsen

190 papers receiving 7.7k citations

Peers

Countries citing papers authored by Jesper Eugen‐Olsen

Since Specialization

Citations

This map shows the geographic impact of Jesper Eugen‐Olsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesper Eugen‐Olsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesper Eugen‐Olsen more than expected).

Fields of papers citing papers by Jesper Eugen‐Olsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesper Eugen‐Olsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesper Eugen‐Olsen. The network helps show where Jesper Eugen‐Olsen may publish in the future.

Co-authorship network of co-authors of Jesper Eugen‐Olsen

This figure shows the co-authorship network connecting the top 25 collaborators of Jesper Eugen‐Olsen. A scholar is included among the top collaborators of Jesper Eugen‐Olsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesper Eugen‐Olsen. Jesper Eugen‐Olsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Soluble urokinase plasminogen activator receptor and interleukin‐6 improves prediction of all‐cause mortality and major adverse cardiovascular events in Type 1 diabetes 2025 ·Journal of Internal Medicine ·(unknown), (unknown), Jens Dahlgaard Hove, Ulrik Dixen, Line Jee Hartmann Rasmussen, Jesper Eugen‐Olsen, (unknown), Magnus T. Jensen	1
2	Development and validation of prognostic machine learning models for short- and long-term mortality among acutely admitted patients based on blood tests 2024 ·Scientific Reports ·(unknown), (unknown), (unknown), Jesper Eugen‐Olsen, Jan O. Nehlin, Ove Andersen, Thomas Kallemose	8
3	Prospective and External Validation of Machine Learning Models for Short- and Long-Term Mortality in Acutely Admitted Patients Using Blood Tests 2024 ·Journal of Clinical Medicine ·(unknown), (unknown), Jesper Eugen‐Olsen, (unknown), (unknown), Line Jee Hartmann Rasmussen, Martin Schultz, Kasper Iversen, (unknown), Thomas Kallemose, Ove Andersen, Jan O. Nehlin	1
4	Overall and inter‐individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes 2023 ·Diabetes Obesity and Metabolism ·Viktor Rotbain Curovic, Morten Baltzer Houlind, (unknown), Niels Jongs, Emilie H. Zobel, Tine W. Hansen, Juliette Tavenier, Jesper Eugen‐Olsen, Gozewijn D. Laverman, Adriaan Kooy, Frederik Persson, Peter Rossing, Hiddo J.L. Heerspink	1
5	Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease 2022 ·Clinical Kidney Journal ·(unknown), Thomas Kallemose, Mads Hornum, (unknown), Jan O. Nehlin, Line Jee Hartmann Rasmussen, (unknown), Juliette Tavenier, Bo Feldt‐Rasmussen, Ove Andersen, Jesper Eugen‐Olsen, Morten Baltzer Houlind	4
6	Sinus bradycardia is associated with poor outcome in critically ill patients with COVID-19 due to the B.1.1.7 Lineage 2021 ·Toxicology Reports ·Athanasios Chalkias, Ioannis Pantazopoulos, Nikolaos Papagiannakis, (unknown), Eleni Laou, Konstantina Kolonia, (unknown), (unknown), (unknown), Christos F. Kampolis, Luis García de Guadiana‐Romualdo, (unknown), Jesper Eugen‐Olsen, Konstantinos I. Gourgoulianis, Eleni Αrnaoutoglou	6
7	Evaluation of commercially available immuno‐magnetic agglutination in comparison to enzyme‐linked immunosorbent assays for rapid point‐of‐care diagnostics of COVID‐19 2021 ·Journal of Medical Virology ·(unknown), Jeppe Fock, (unknown), (unknown), (unknown), Marco Donolato, Simone Bastrup Israelsen, Jesper Eugen‐Olsen, Thomas Benfield, Frederik Neess Engsig	7
8	Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19 2021 ·Journal of Clinical Medicine ·Salim S. Hayek, Christoph Roderburg, Pennelope Blakely, (unknown), Jesper Eugen‐Olsen, Frank Tacke, Sofia Ira Ktena, Verena Keitel, Mark Luedde, Evangelos J. Giamarellos‐Bourboulis, Tom Luedde, Sven H. Loosen	14
9	High suPAR and Low Blood Eosinophil Count are Risk Factors for Hospital Readmission and Mortality in Patients with COPD 2020 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Thomas Kallemose, Ove Andersen, Jesper Eugen‐Olsen, Kristoffer Marsaa, (unknown)	1
10	Availability of suPAR in emergency departments may improve risk stratification: a secondary analysis of the TRIAGE III trial 2019 ·Scandinavian Journal of Trauma Resuscitation and Emergency Medicine ·Martin Schultz, Line Jee Hartmann Rasmussen, Thomas Kallemose, Erik Kjøller, (unknown), (unknown), Theis Lange, Lars Køber, Lars S. Rasmussen, Jesper Eugen‐Olsen, Kasper Iversen	18
11	Early Discharge from the Emergency Department Based on Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels: A TRIAGE III Substudy 2019 ·Disease Markers ·Martin Schultz, Line Jee Hartmann Rasmussen, Thomas Høi-Hansen, Erik Kjøller, Birgitte Nybo Jensen, (unknown), (unknown), Thomas Kallemose, Theis Lange, Lars Køber, Lars S. Rasmussen, Jesper Eugen‐Olsen, Kasper Iversen	18
12	Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD 2018 ·Respiratory Research ·Nina Godtfredsen, (unknown), Kristoffer Marsaa, Charlotte Suppli Ulrik, Ove Andersen, Jesper Eugen‐Olsen, Line Jee Hartmann Rasmussen	19
13	Weight loss is superior to exercise in improving the atherogenic lipid profile in a sedentary, overweight population with stable coronary artery disease: A randomized trial 2016 ·Atherosclerosis ·Lene Rørholm Pedersen, R H Olsen, Christian Anholm, Rosemary L. Walzem, Mogens Fenger, Jesper Eugen‐Olsen, Steen B. Haugaard, Eva Prescott	25
14	Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1–Infected Individuals 2016 ·The Journal of Infectious Diseases ·Troels Bygum Knudsen, (unknown), Janne Petersen, Holger Jon Møller, Søren K. Moestrup, Jesper Eugen‐Olsen, Gitte Kronborg, Thomas Benfield	105
15	Increased Plasma Soluble uPAR Level Is a Risk Marker of Respiratory Cancer in Initially Cancer-Free Individuals 2011 ·Cancer Epidemiology Biomarkers & Prevention ·Anne Langkilde, Tine W. Hansen, Steen Ladelund, Allan Linneberg, Ove Andersen, Steen B. Haugaard, Jørgen Jeppesen, Jesper Eugen‐Olsen	46
16	The immune marker soluble urokinase plasminogen activator receptor is associated with new‐onset diabetes in non‐smoking women and men 2011 ·Diabetic Medicine ·Steen B. Haugaard, Ove Andersen, Tine W. Hansen, Jesper Eugen‐Olsen, Allan Linneberg, Sten Madsbad, Michael Hecht Olsen, Torben Jørgensen, K. Borch‐Johnsen, Jørgen Jeppesen	24
17	No Influence of GB Virus C on Disease Progression in a Danish Cohort of HIV-Infected Men 2006 ·AIDS Research and Human Retroviruses ·(unknown), Terese L. Katzenstein, Jan Gerstoft, Jesper Eugen‐Olsen	10
18	Immunological Predictors of Survival in HIV Type 2-Infected Rural Villagers in Guinea-Bissau 2005 ·AIDS Research and Human Retroviruses ·Shabbar Jaffar, Maarten Schim van der Loeff, Jesper Eugen‐Olsen, Tim Vincent, (unknown), Pa Tamba N’Gom, Anne‐Marie Meyer, Neil Berry, Peter Aaby, Hilton Whittle	17
19	The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau. 2002 ·Lund University Publications (Lund University) ·Jesper Eugen‐Olsen, Per Gustafson, Nicolai Sidénius, Thea Kølsen Fischer, Jan Parner, Peter Aaby, V. Gomes, Ida Maria Lisse	127
20	A new multiplex PCR strategy for the simultaneous determination of four genetic polymorphisms affecting HIV-1 disease progression 2001 ·Journal of Immunological Methods ·Thomas Birk Kristiansen, Troels Bygum Knudsen, (unknown), Jesper Eugen‐Olsen	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact